Literature DB >> 15812783

Convenient access both to highly antimalaria-active 10-arylaminoartemisinins, and to 10-alkyl ethers including artemether, arteether, and artelinate.

Richard K Haynes1, Ho-Wai Chan, Wing-Yan Ho, Cliff Ki-Fung Ko, Lucia Gerena, Dennis E Kyle, Wallace Peters, Brian L Robinson.   

Abstract

An economical phase-transfer method is used to prepare 10-arylaminoartemisinins from DHA and arylamines, and artemether, arteether, and artelinate from the corresponding alcohols. In vivo sc screens against Plasmodium berghei and P. yoelii in mice reveal that the p-fluorophenylamino derivative 5 g is some 13 and 70 times, respectively, more active than artesunate; this reflects the very high sc activity of 10-alkylaminoartemisinins. However, through the po route, the compounds are less active than the alkylaminoartemisinins, but still approximately equipotent with artesunate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15812783     DOI: 10.1002/cbic.200400366

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  7 in total

1.  Electronically stabilized versions of the antimalarial acetal trioxanes artemether and artesunate.

Authors:  Gary H Posner; William A Maio; Alvin S Kalinda
Journal:  Bioorg Med Chem       Date:  2008-03-06       Impact factor: 3.641

2.  Artemisone and Artemiside Are Potent Panreactive Antimalarial Agents That Also Synergize Redox Imbalance in Plasmodium falciparum Transmissible Gametocyte Stages.

Authors:  Dina Coertzen; Janette Reader; Mariëtte van der Watt; Sindisiwe H Nondaba; Liezl Gibhard; Lubbe Wiesner; Peter Smith; Sarah D'Alessandro; Donatella Taramelli; Ho Ning Wong; Jan L du Preez; Ronald Wai Keung Wu; Lyn-Marie Birkholtz; Richard K Haynes
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

3.  Hybrid Gold(I) NHC-Artemether Complexes to Target Falciparum Malaria Parasites.

Authors:  Manel Ouji; Guillaume Barnoin; Álvaro Fernández Álvarez; Jean-Michel Augereau; Catherine Hemmert; Françoise Benoit-Vical; Heinz Gornitzka
Journal:  Molecules       Date:  2020-06-18       Impact factor: 4.411

4.  Optimal 10-Aminoartemisinins With Potent Transmission-Blocking Capabilities for New Artemisinin Combination Therapies-Activities Against Blood Stage P. falciparum Including PfKI3 C580Y Mutants and Liver Stage P. berghei Parasites.

Authors:  Ho Ning Wong; Vivian Padín-Irizarry; Mariëtte E van der Watt; Janette Reader; Wilna Liebenberg; Lubbe Wiesner; Peter Smith; Korina Eribez; Elizabeth A Winzeler; Dennis E Kyle; Lyn-Marie Birkholtz; Dina Coertzen; Richard K Haynes
Journal:  Front Chem       Date:  2020-01-10       Impact factor: 5.221

5.  In Vitro Activity of the Arylaminoartemisinin GC012 against Helicobacter pylori and Its Effects on Biofilm.

Authors:  Francesca Sisto; Simone Carradori; Sarah D'Alessandro; Nadia Santo; Norma Lattuada; Richard K Haynes; Donatella Taramelli; Rossella Grande
Journal:  Pathogens       Date:  2022-06-29

6.  Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether.

Authors:  Daniel J Watson; Lizahn Laing; Liezl Gibhard; Ho Ning Wong; Richard K Haynes; Lubbe Wiesner
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

7.  Facile Preparation of N-Glycosylated 10-Piperazinyl Artemisinin Derivatives and Evaluation of Their Antimalarial and Cytotoxic Activities.

Authors:  Yuet Wu; Silvia Parapini; Ian D Williams; Paola Misiano; Ho Ning Wong; Donatella Taramelli; Nicoletta Basilico; Richard K Haynes
Journal:  Molecules       Date:  2018-07-13       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.